We came across a bullish thesis on Recursion Pharmaceuticals, Inc. on r/stocks by Antique-Reference585. In this article, we ...
SALT LAKE CITY - Recursion Pharmaceuticals (NASDAQ:RXRX) announced Monday that its investigational drug REC-4881 demonstrated significant polyp reduction in patients with familial adenomatous ...